Boussard & Gavaudan Investment Management LLP Seagen Inc. Transaction History

Boussard & Gavaudan Investment Management LLP

  • $407 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$191.51 - $216.16 $321,353 - $362,716
1,678 Added 0.8%
212,105 $45 Million
Q2 2023

Aug 11, 2023
BUY
$187.64 - $206.25 $39.5 Million - $43.4 Million
210,427 New
210,427 $40.5 Million

Others Institutions Holding SGEN

# of Institutions
39
Shares Held
1.26M
Call Options Held
23K
Put Options Held
55.2K
View Full List

About Seagen Inc.

SGEN Quotes by TradingView
  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Boussard & Gavaudan Investment Management LLP Portfolio

Follow Boussard & Gavaudan Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email